Contineum Therapeutics Inc. - Ordinary Shares - Class A XNAS: CTNM

Contineum Therapeutics Inc. - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Contineum Therapeutics Inc. - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Contineum Therapeutics Inc. - Ordinary Shares - Class A
Rating: 0.92858325
Author: Trendlyne DVM scores

Download real time

7.07 -0.38 (-5.10%)

67.75% Fall from 52W High

44,901 XNAS Volume

XNAS 28 Mar, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Contineum Therapeutics Inc. - Ordinary Shares - Class A is on 31 Mar 2025 for the purpose of Contineum Therapeutics Inc Annual Report for 2024 See details

Not Eligible

-

Expensive Valuation

11.3 / 100

Technically Bearish

25.8 / 100

29

1Yr Price target upside is 314%

4 analysts

Contineum Therapeutics Inc... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Contineum Therapeutics Inc. - Ordinary Shares - Class A FAQ

How is Contineum Therapeutics Inc. - Ordinary Shares - Class A today?

Contineum Therapeutics Inc. - Ordinary Shares - Class A today is trading in the red, and is down by -5.10% at 7.07.

How has Contineum Therapeutics Inc. - Ordinary Shares - Class A performed historically?

Contineum Therapeutics Inc. - Ordinary Shares - Class A is currently trading down -5.10% on an intraday basis. In the past week the stock fell -1.39%. stock has been down -50.59% in the past quarter and fell None% in the past year. You can view this in the overview section.